Class Review Schedule

The Department will be reviewing the following classes at the July 14, 2022 D&T Advisory Board Meeting:

Hematopoeitic Agents

In addition, it will review the following Agenda Requested Drugs:

Vraylar

Invega Hafyera

Voxzogo

Vyvgart

All clinical and financial submissions are due to the Department by 3:00pm CST June, 23, 2022.  Please submit to: HFS.SupplementalRebateProgram@illinois.gov.

.

​